In Search of Mechanisms of Change in Treatment Outcome Research: Mediators and Moderators of Psychological and Pharmacological Treatments for Irritable Bowel Syndrome

Gastroenterology

Volumn 133, Issue 2, 2007, Pages 702-705

  Labus, Jennifer S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; EDITORIAL; HUMAN; HYPNOSIS; IRRITABLE COLON; LOW DRUG DOSE; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 34547498798     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.06.052     Document Type: Editorial

References (35)

1. Gershon M.D., and Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132 (2007) 397-414
2. Mayer E.A., Naliboff B.D., and Craig A.D. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 131 (2006) 1925-1942
3. Blanchard E.B., and Scharff L. Psychosocial aspects of assessment and treatment of irritable bowel syndrome in adults and recurrent abdominal pain in children. J Consult Clin Psychol 70 (2002) 725-738
4. Lackner J.M., Mesmer C., Morley S., et al. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J Consult Clin Psychol 72 (2004) 1100-1113
5. Wilson S., Maddison T., Roberts L., et al., Birmingham IBS Research Group. Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome. Aliment Pharmacol Ther 24 (2006) 769-780
6. Gholamrezaei A., Ardestani S.K., and Emami M.H. Where does hypnotherapy stand in the management of irritable bowel syndrome?. A systematic review. J Altern Complement Med 12 (2006) 517-527
7. Whitehead W.E. Hypnosis for irritable bowel syndrome: the empirical evidence of therapeutic effects. Int J Clin Exp Hypn 54 (2006) 7-20
8. Blanchard E.B., Lackner J.M., Sanders K., et al. A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome. Behav Res Ther 45 (2007) 633-648
9. Vlieger A.M., Menko-Frankenhuis C., Wolfkamp S.C., et al. Hypnotherapy for children with function abdominal pain or irritable bowel syndrome: a randomized controlled trial. Gastroenterology (2007) [in Press]
10. Tan G., Hammond D.C., and Joseph G. Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action. Am J Clin Hypn 47 (2005) 161-178
11. Guthrie E., Barlow J., Fernandes L., et al., North of England IBS Research Group. Changes in tolerance to rectal distension correlate with changes in psychological state in patients with severe irritable bowel syndrome. Psychosom Med 66 (2004) 578-582
12. Cremonini F., Delgado-Aros S., and Camilleri M. Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil 15 (2003) 79-86
13. Evans B.W., Clark W.K., Moore D.J., et al. Tegaserod for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev (2004) CD003960
14. Jackson J.L., O'Malley P.G., Tomkins G., et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 108 (2000) 65-72
15. Holroyd K.A., O'Donnell F.J., Stensland M., et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 285 (2001) 2208-2215
16. Holroyd K.A., and Penzien D.B. Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials. Pain 42 (1990) 1-13
17. Holroyd K.A., and Drew J.B. Behavioral approaches to the treatment of migraine. Semin Neurol 26 (2006) 199-207
18. Holroyd K.A., Lipchik G.L., and Penzien D.B. Psychological management of recurrent headache disorders: empirical basis for clinical practice. In: Dobson K.S., and Craig K.D. (Eds). Best Practice: Developing and Promoting Empirically Supported Interventions (1998), Sage, Newbury Park, CA 193-212
19. Kraemer H.C., Wilson G.T., Fairburn C.G., et al. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 59 (2002) 877-883
20. Baron R.M., and Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51 (1986) 1173-1182
21. Laurenceau J.P., Hayes A.M., and Feldman G.C. Some methodological and statistical issues in the study of change processes in psychotherapy. Clin Psychol Rev (2007) in press
22. MacKinnon D.P., Fairchild A.J., and Fritz M.S. Mediation analysis. Annu Rev Psychol 58 (2007) 593-614
23. Simren M. Hypnosis for irritable bowel syndrome: the quest for the mechanism of action. Int J Clin Exp Hypn 54 (2006) 65-84
24. Palsson O.S., Turner M.J., Johnson D.A., et al. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci 47 (2002) 2605-2614
25. Creed F., Guthrie E., Ratcliffe J., et al., North of England IBS Research Group. Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder?. Aust N Z J Psychiatry 39 (2005) 807-815
26. Lackner J.M., Jaccard J., Krasner S.S., et al. How does cognitive behavior therapy for irritable bowel syndrome work?. A mediational analysis of a randomized clinical trial. Gastroenterology 133 (2007) 433-444
27. Walkup J.T., Labellarte M.J., Riddle M.A., et al., Research Units on Pediatric Psychopharmacology Anxiety Study Group. Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 42 (2003) 13-21
28. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: The Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56 (1999) 1088-1096
29. Curry J., Rohde P., Simons A., et al., TADS Team. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 45 (2006) 1427-1439
30. Shrout P.E., and Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods 7 (2002) 422-445
31. MacKinnon D.P., Lockwood C.M., Hoffman J.M., et al. A comparison of methods to test mediation and other intervening variable effects. Psychol Meth 7 (2002) 83-104
32. Jaccard J., Guilamo-Ramos V., Johansson M., et al. Multiple regression analyses in clinical child and adolescent psychology. J Clin Child Adolesc Psychol 35 (2006) 456-479
33. Edwards J.R., and Lambert L.S. Methods for integrating moderation and mediation: a general analytical framework using moderated path analysis. Psychol Meth 12 (2007) 1-22
34. Camilleri M., Mangel A.W., Fehnel S.E., et al. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol 5 (2007) 534-540
35. Committee DoT.T., Irvine E.J., Whitehead W.E., et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 130 (2006) 1538-1551